Animal experimental research assessing urogynecologic surgical mesh implants: Outcome measures describing the host response, a systematic review and meta-analysis.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
06 2021
Historique:
revised: 17 02 2021
received: 09 12 2020
accepted: 05 04 2021
pubmed: 6 5 2021
medline: 1 10 2021
entrez: 5 5 2021
Statut: ppublish

Résumé

Before the introduction of new biomaterials for prolapse surgery, animal studies on the host response are required. Unfortunately, large variation in study design hampers obtaining an overview of the safety and efficacy, and translation to clinical practice. Our aim is to systematically review the literature on all outcome measures describing the host response in animal studies assessing the biocompatibility of urogynecologic surgical mesh implants for prolapse surgery. Furthermore, by meta-analysis, we aim to assess the effect of implantation and compare this to control animals receiving sham surgery or native tissue repair. We performed a systematic search from inception to August 2020. Since this is an explorative study we included original, controlled, and noncontrolled animal studies describing any host response to the implant. Quantitative outcome measures reported ≥10 times in ≥2 articles were eligible for meta-analysis. Fifty articles were included in the qualitative synthesis and 36 articles were eligible for meta-analysis. In total, 154 outcome measures were defined and classified into (1) histomorphology, (2) biomechanics and, (3) macroscopic morphology. Animals with vaginal implants demonstrated significantly increased M1 and M2 macrophages, MMP-2, neovascularization, TNF-α, and stiffness, and lower vaginal contractility compared to control animals. The host response significantly differs in animals after vaginal mesh implantation compared to control animals, both pro- and anti-inflammatory. However, we observed a paucity in the uniformity of reported outcomes. For future animal studies, we propose the development of a core outcome set, which ideally predicts the host response in women.

Identifiants

pubmed: 33951222
doi: 10.1002/nau.24677
pmc: PMC8359983
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1107-1119

Informations de copyright

© 2021 The Authors. Neurourology and Urodynamics published by Wiley Periodicals LLC.

Références

J Biomed Mater Res A. 2008 Jan;84(1):158-66
pubmed: 17607751
Obstet Gynecol. 1997 Apr;89(4):501-6
pubmed: 9083302
Neurourol Urodyn. 2017 Jan;36(1):73-79
pubmed: 26436858
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Int Urogynecol J. 2017 Feb;28(2):171-180
pubmed: 27216918
Biomaterials. 2009 Mar;30(8):1482-91
pubmed: 19121538
Am J Obstet Gynecol. 2016 Aug;215(2):206.e1-8
pubmed: 27094962
BJOG. 2013 Jan;120(2):244-250
pubmed: 23240803
BMC Med Res Methodol. 2014 Mar 26;14:43
pubmed: 24667063
Altern Lab Anim. 2010 May;38(2):167-82
pubmed: 20507187
Int Urogynecol J. 2012 Jun;23(6):669-79
pubmed: 22430945
Am J Obstet Gynecol. 2008 May;198(5):555.e1-5
pubmed: 18355779
Int Urogynecol J. 2012 Apr;23 Suppl 1:S15-26
pubmed: 22395289
Sci Rep. 2019 Jan 29;9(1):822
pubmed: 30696832
PLoS One. 2018 Jan 11;13(1):e0187271
pubmed: 29324741
Semin Immunol. 2008 Apr;20(2):86-100
pubmed: 18162407
Am J Obstet Gynecol. 2006 Dec;195(6):1826-31
pubmed: 17026951
Cochrane Database Syst Rev. 2016 Feb 09;2:CD012079
pubmed: 26858090
Biomed Res Int. 2015;2015:968087
pubmed: 25977927
BJOG. 2013 Jan;120(2):233-243
pubmed: 23240802
Int Urogynecol J. 2012 Oct;23(10):1397-402
pubmed: 22527542
Curr Opin Obstet Gynecol. 2016 Oct;28(5):413-9
pubmed: 27517341
Int Urogynecol J. 2016 Oct;27(10):1547-55
pubmed: 26992722
J Pelvic Med Surg. 2009 May;15(3):105-114
pubmed: 22229022
Obstet Gynecol. 2011 Sep;118(3):629-636
pubmed: 21860293
Neurourol Urodyn. 2021 Jun;40(5):1107-1119
pubmed: 33951222
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
JAMA. 2008 Sep 17;300(11):1311-6
pubmed: 18799443
BJOG. 2013 Jan;120(2):224-232
pubmed: 23240801
J Physiol. 2020 Sep;598(18):3793-3801
pubmed: 32666574
Curr Opin Urol. 2019 Jul;29(4):400-406
pubmed: 31008781
Am J Obstet Gynecol. 2015 Feb;212(2):174.e1-7
pubmed: 25128444

Auteurs

Kim W J Verhorstert (KWJ)

Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Aksel N Gudde (AN)

Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Brita S Kortz (BS)

Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jacqueline Limpens (J)

Medical Library, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jan-Paul W R Roovers (JWR)

Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Carlijn R Hooijmans (CR)

Department for Health Evidence unit SYRCLE, Radboud University Medical Center, Nijmegen, The Netherlands.

Zeliha Guler (Z)

Department of Obstetrics and Gynecology, Amsterdam Reproduction and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH